Hybio Pharmaceutical Co., Ltd. (300199.SZ)

CNY 14.06

(3.23%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.27 Billion 3.61 Billion 3.9 Billion 4.02 Billion 4.72 Billion 5.66 Billion
Total Current Assets 683.63 Million 812.32 Million 1.15 Billion 1.04 Billion 1.89 Billion 3.02 Billion
Cash And Short Term Investments 344 Million 266.83 Million 616.59 Million 451.64 Million 820.76 Million 1.56 Billion
Cash and Cash Equivalents 344 Million 106.26 Million 138.92 Million 451.64 Million 820.76 Million 1.56 Billion
Short Term Investments -255.68 Million 160.56 Million 477.67 Million -59.32 Million -108.24 Million -149.52 Million
Net Receivables 164.01 Million 341.9 Million 338.75 Million 360.14 Million 852.44 Million 1.26 Billion
Inventory 152.59 Million 189.95 Million 157.13 Million 186.76 Million 152 Million 161.61 Million
Other Current Assets 23.01 Million 13.62 Million 42.58 Million 48.47 Million 67.56 Million 34.97 Million
Total Non-Current Assets 2.59 Billion 2.79 Billion 2.75 Billion 2.97 Billion 2.83 Billion 2.63 Billion
Net PPE 1.73 Billion 1.94 Billion 1.99 Billion 1.98 Billion 1.79 Billion 1.32 Billion
Good Will And Intangible Assets 429.58 Million 507.3 Million 479.39 Million 550.89 Million 552.89 Million 864.58 Million
Good Will - - 191.12 Thousand - - 343.56 Million
Intangible Assets 429.58 Million 507.3 Million 479.2 Million 550.89 Million 552.89 Million 521.02 Million
Long-Term Investments 280.58 Million -127.01 Million -442.7 Million 259.25 Million 277.25 Million 309.09 Million
Tax Assets 39.54 Million 38.01 Million 34.07 Million 37.72 Million 51.92 Million 48.92 Million
Other Non Current Assets 109.71 Million 438.78 Million 688.02 Million 145.04 Million 159.22 Million 88.31 Million
Other Assets - - - - - -
Total Liabilities 2.49 Billion 2.31 Billion 2.25 Billion 2.34 Billion 2.49 Billion 2.26 Billion
Total Current Liabilities 1.42 Billion 1.14 Billion 743.81 Million 1.09 Billion 1.13 Billion 831.92 Million
Account Payables 108.49 Million 129.05 Million 90.72 Million 125.48 Million 130.11 Million 74.42 Million
Tax Payables 5.55 Million 21.18 Million 16.75 Million 3.48 Million 656.2 Thousand 32.09 Million
Short Term Debt 1.07 Billion 774.91 Million 412.33 Million 801.81 Million 763.49 Million 419.81 Million
Deferred Revenue 234 Million 234.43 Million 232.52 Million 165.23 Million 177.56 Million 271.31 Million
Other Current Liabilities 10.34 Million 9.55 Million 8.22 Million 4.47 Million 64.54 Million 66.36 Million
Total Non Current Liabilities 1.07 Billion 1.16 Billion 1.51 Billion 1.24 Billion 1.35 Billion 1.43 Billion
Long-Term Debt 938.55 Million 1.02 Billion 1.37 Billion 1.14 Billion 1.26 Billion 1.34 Billion
Deferred Revenue Non Current 101.18 Million 118.61 Million 124.72 Million 90.54 Million 87.72 Million 80.02 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 25.78 Million 20.55 Million 15.79 Million 9.75 Million 3.5 Million 3.5 Million
Other Liabilities -0.00 1.00 1.00 1.00 - -
Total Equity 783.21 Million 1.29 Billion 1.64 Billion 1.67 Billion 2.23 Billion 3.39 Billion
Stock Holders Equity 758.8 Million 1.27 Billion 1.58 Billion 1.63 Billion 2.22 Billion 3.39 Billion
Common Stock 883.24 Million 916.92 Million 916.92 Million 916.92 Million 916.92 Million 927.74 Million
Retained Earnings -1.68 Billion -1.17 Billion -796.69 Million -827.49 Million -218.07 Million 664.61 Million
Accumulated other comprehensive income 39.26 Million 211.03 Million 183.48 Million 215.7 Million -112.01 Million 131.22 Million
Common Stock Equity 758.8 Million 1.27 Billion 1.58 Billion 1.63 Billion 2.22 Billion 3.39 Billion
Capital Lease Obligation 208.05 Thousand 2.87 Million 11.05 Million 11.05 Million - -
Total Investments 24.89 Million 33.55 Million 34.97 Million 199.93 Million 169 Million 159.57 Million
Total Debt 2 Billion 1.79 Billion 1.78 Billion 1.94 Billion 2.02 Billion 1.76 Billion
Net Debt 1.66 Billion 1.69 Billion 1.64 Billion 1.49 Billion 1.2 Billion 203.57 Million

Balance Sheet Charts